What is Braintrain 20:20?
Braintrain 20:20 is developing an innovative product designed to promote sleep through a unique wind-down process. The company leverages cognitive behavioral therapy (CBT) delivered via personalized biofeedback, utilizing visual, auditory, and tactile cues. This approach aims to help users relearn healthy sleep patterns by measuring physiological and behavioral indicators, thereby guiding them swiftly and effectively toward sleep initiation. The company's focus on data-driven, personalized sleep solutions positions it within the growing digital health and wellness market.
How much funding has Braintrain 20:20 raised?
Braintrain 20:20 has raised a total of $591K across 1 funding round:
Angel/Seed
$591K
Angel/Seed (2016): $591K with participation from Mercia Fund Management
Key Investors in Braintrain 20:20
Mercia Fund Management
Mercia Fund Management is a UK-based venture capital firm specializing in early-stage and growth-stage companies, likely focusing on technology and healthcare innovations.
What's next for Braintrain 20:20?
The recent major strategic investment indicates Braintrain 20:20 is likely in a growth or scaling phase, aiming to expand its product development, market reach, and technological capabilities. This enterprise-level funding suggests confidence from investors in the company's potential to disrupt the sleep aid market. Future developments may include further refinement of its biofeedback technology, broader clinical validation, and strategic partnerships to integrate its solution into existing healthcare or wellness platforms.
See full Braintrain 20:20 company page
